window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : July 23, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Patient Outcomes

  • Drug Discovery & Development,Manufacturing & Supply Chain,Medical devices,Opinion & Events,Pharmaceuticals and therapeutics

    Lungpacer receives CMS NTAP approval for AeroPace system, enhancing care for mechanically ventilated patients

    Lungpacer Medical has received CMS New Technology Add-on Payment approval [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Opinion & Events

    OMNY Health dataset surpasses 100M patients, creating largest US repository of unstructured clinical data

    OMNY Health has reached a major milestone, announcing that its [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Opinion & Events

    NICE recommends Mirikizumab for moderately to severely active Crohn’s Disease after biologic failure

    Mirikizumab is now recommended by NICE for routine NHS use [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development

    Why patient-centric trial design is the future of oncology: Q&A with One2Treat’s chief medical officer Pascal Piedbois

    As oncology research continues to evolve, the focus is increasingly [...]

    May 5, 2026
  • Digital & Data

    ICU level care not definitive indicator for sepsis, new study shows

    May 5, 2026
  • Drug Delivery & Formulation

    FDA approves compassionate use of reverse hip replacement system for spinal fusion patients

    April 24, 2025

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Rani reports positive Phase 1 data for oral obesity therapy RT-114
    Categories: Clinical & Regulatory, Drug Delivery & Formulation, Pharmaceuticals and therapeutics, Research & Development
  • Seegene launches global study to evaluate comprehensive PCR testing for respiratory infections
    Categories: Clinical & Regulatory, Digital & Data, Genomics and sequencing, Research & Development
  • Adneuris licenses Phase 3 pain therapy cebranopadol to Conba for Greater China
    Categories: Biotech & Pharma Business, Clinical & Regulatory, Drug Discovery & Development, Pharmaceuticals and therapeutics
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top